X-ray crystallographic structure-based design of selective thienopyrazole inhibitors for interleukin-2-inducible

Larry R McLean1, Ying Zhang, Nisha Zaidi

  • 1Molecular Innovative Therapeutics, Sanofi US, 1041 Route 202/206 N, Bridgewater, NJ 08807, United States. Larry.McLean@sanofi.com

Related Concept Videos